Inviro Medical Devices Secures Top Leadership, Positioning Company for Long-Term Success

ATLANTA – November 7, 2006 – With the appointment of a board chairman, another experienced board member, chief financial officer and executive vice president, distributor sales, Inviro Medical Devices (www.inviromedical.com) has secured seasoned executives for top leadership and management positions, as well as completed recruitment of its U.S. sales force. These efforts will support the company’s aggressive North American launch of the Inviro Safety System and its flagship infection control product, the InviroSNAP!® Safety Syringe.

Dr. Tony Holler, appointed to the board of the infection control products company during April, was named chairman of the board this August. Holler was one of the original founders of ID Biomedical Corporation and held a number of executive positions with the company, including CEO. He resigned from the vaccine manufacturing company in December 2005 upon the completion of its acquisition by GlaxoSmithKline for $1.4 billion.

Todd Patrick, former president and chief operating officer of ID Biomedical also has been appointed to Inviro Medical’s board. He brings considerable commercial and financial experience within the biomedical industry, as well as a strong background in intellectual property matters, all highly relevant to Inviro’s future development plans, particularly in regard to its infection control products.

Inviro Medical Devices also named Michael Poelking as chief financial officer. In a career spanning nearly three decades, Poelking has held financial leadership positions at numerous high-profile companies in multiple industries, including manufacturing and distribution, healthcare, consumer products and business to business. Most recently, he served as senior vice president and chief financial officer of GF Health Products, Inc. a manufacturer and distributor of durable medical equipment servicing the home and long-term health care industries.

Veteran healthcare sales and marketing professional Michael Atkinson also joins the Inviro Medical Devices team as executive vice president, distributor sales, and will focus on growing existing relationships with major distributors addressing the alternate care market. Formerly, he served as president of SafePro. Inviro Medical recently entered
into an exclusive, long-term agreement to sell, market and distribute SafePro safety syringes in the U.S. and Canada. Atkinson’s efforts will both balance and enhance Inviro’s historic emphasis on the acute care market as the company expands its lines of safety syringes and other infection control products.

“These high caliber leaders help position the company for long-term success,” says Gareth Clarke, chief executive officer of Inviro Medical Devices. “Dr. Holler’s expertise has already been instrumental in securing a recent $12 million round of funding. Mr. Patrick adds considerable, highly relevant experience to our Board. Mr. Poelking is a driven transformational leader who has a tremendous record of developing successful corporate strategies and earning the trust of key constituents. In addition,” Clarke adds, “Mr. Atkinson will enable our innovative infection control products to expand into physicians’ offices, surgical centers and long-term care facilities.”

Clarke’s leadership of Inviro Medical Devices recently received global recognition when he was invited to present information about the company and its infection control products at the prestigious UBS Global Life Sciences Conference in New York during September. The event is one of the largest healthcare investor conferences in the world and features presentations by elite public and private companies in biotechnology, medical device manufacturing, pharmaceuticals and specialty pharmaceuticals.

In addition to these appointments and activities, the company’s U.S. sales team for the InviroSNAP! Safety Syringe and its other infection control products is now in place. Five Regional Vice-Presidents now ensure comprehensive coverage across the United States:
• Michelle Fleming, Southern Region based in Dallas, Texas
• Ted Curry, Western Region based in Sacramento, California
• Charles Farry, Southeast Region based in Charlotte, North Carolina
• Rick Fedie, Northern Region based in Minneapolis, Minnesota
• John Farneth, Northeast Region based in Pittsburgh, Pennsylvania


About Inviro Medical Devices

Founded in 1988, Inviro Medical Devices engineers and markets safe medication delivery systems, including the patented InviroSNAP! Safety Syringe. After years of research to develop its patents and refine its product designs, the company is addressing the growing $1.6 billion safety syringe market and introducing its breakthrough infection control technology in North America. Headquartered in Atlanta, Inviro Medical Devices is becoming a leading industry champion in the quest to protect healthcare workers, patients and the environment with innovative medical devices. For more information, visit www.inviromedical.com.